(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
the recent VAD innovations from the Ventricular Assist Device (VAD) program at
the Heart Institute at Cincinnati Children’s Hospital, include:
In July of 2012, a Berlin EXCOR was placed in a 12 month old
boy with restrictive cardiomyopathy. This device implantation was unusual
because of its cannula placement, in the left atrium. The child was
transplanted without complication and is back at home in Kentucky.
In September 2012, David L.S. Morales, MD and team implanted the first VAD
in a Duchenne muscular dystrophy (DMD) patient in the United States. This
patient had a HeartMate II implanted, was discharged to home and is now
followed in the VAD / Destination clinic.
In November of 2012, our program implanted a SynCardia Total
Artificial (TAH) Heart into a 19-year-old woman with transplant rejection,
making her the first female at a children’s hospital to undergo this
In January of 2013, the Cincinnati Children's Hospital Medical Center SynCardia patient was transferred
to the Freedom Driver to prepare for discharge home. Only 30 patients in the US
have been discharged home on this device.
In February of 2013, the first female DMD patient (very rare for
disease to affect a female) had a HeartWare device placed. She was discharged
and followed in the VAD/Destination clinic and is preparing to go home to
In July of 2013, a 3 year old boy had a Berlin implanted for
cardiac failure and subsequently received 5 rounds of chemotherapy successfully.
He is now listed for transplant.
Training and Research (Cincinnati Children’s Center for Mechanical
Circulatory Support (MCS) Education and Innovation)
VAD / MCS program is an international training site for the Berlin Excor device.
Surgical training and in situ simulations are offered to visiting groups.
Recently, our program hosted a training session for surgeons from Brazil and
Japan, sharing knowledge from implantation to post-op care and long-term
Children’s is part of many investigational trials for new and existing devices.
We are currently part of the Berlin EXCOR post approval study, the SynCardia 50
cc device trial, and we are enrolling consented patient data in a national
registry. We are also part of the
Freedom driver Syncardia study and recently enrolled our first patient.
Visit our Contact Us page for consultation or patient VAD / ECMO transport questions.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2015 Cincinnati Children's Hospital Medical Center